Transcriptomics

Dataset Information

0

Farnesyltransferase inhibition overcomes the adaptive resistance to targeted therapies in oncogene-addicted non-small cell lung cancer II


ABSTRACT: Drug-tolerance has emerged as one of the major non-genetic adaptive processes driving resistance to targeted therapy (TT) in non-small cell lung cancer (NSCLC). However, the kinetics and sequence of molecular events governing this adaptive response remain poorly understood. Here, we performed transcriptomic profiling by RNAseq in a panel of EGFR-mutant NSCLC cell lines (PC9, HCC4006, H3255 and HCC827) that were previously subcloned to minimize the presence of potential pre-existing resistant cells. Cells were treated by either erlotinib (1 µM) or osimertinib (1 µM) for a short period (24h), until drug-tolerance (between 7 and 21 days), and until development of fully resistant proliferative cells (RPC).

ORGANISM(S): Homo sapiens

PROVIDER: GSE249721 | GEO | 2024/05/17

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-05-17 | GSE248450 | GEO
2020-09-03 | GSE121634 | GEO
2016-03-29 | E-GEOD-79688 | biostudies-arrayexpress
2017-09-23 | GSE80344 | GEO
| PRJNA1044045 | ENA
2015-07-31 | GSE71587 | GEO
2015-07-31 | E-GEOD-71587 | biostudies-arrayexpress
| PRJNA1050239 | ENA
2022-03-08 | MSV000089018 | MassIVE
2016-03-29 | GSE79688 | GEO